09:57 AM EST - Bausch Health Companies Inc. : Announced the U.S. launch of its novel daily over-the-counter probiotic supplement, ENVIVE™. ENVIVE™ is shown to help reduce the severity and frequency of five occasional gastrointestinal (GI) symptoms - diarrhea, constipation, gas, bloating and discomfort - and help strengthen and protect the digestive system by strengthening the gut barrier. ENVIVE™ is proven to help relieve these occasional GI symptoms in as little as two weeks.* Bausch Health Companies Inc.
shares T.BHC are trading down $0.08 at $39.73.
